Supply of Pharmaceuticals with the Active Substance Afliberceptum

This tender procedure aims to establish a framework purchase agreement for the supply of medicinal products containing the active substance Afliberceptum, as needed by the contracting authority. The subject of the public contract is classified under code 33662100-9 (Ophthalmologicals) with ATC code S01LA05. The primary objective is to secure a consistent and reliable supply of these specific pharmaceuticals, which are likely used for ophthalmic treatments. The framework agreement will allow the contracting authority to place orders based on their requirements over a defined period. Bidders are expected to demonstrate their capability to supply the specified medicinal products in compliance with all relevant pharmaceutical regulations and quality standards. This procurement is critical for ensuring the availability of essential treatments for patients.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Czech Republic, Europe, this opportunity is open to firms and consortiums, with an estimated budget of CZK 21.6 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.